Transfer rates of 225Ac to exhaust air, surface, and waste water under chemical operations
Creators
- 1. Tohoku University, Institute for Materials Research, Laboratory of Alpha-ray Emitters, Sendai, Miyagi (Japan)
- 2. Tohoku University, Research Center for Electron Photon Science, Sendai, Miyagi (Japan)
- 3. Osaka University, Institute for Radiation Sciences, Radioisotope Research Center, Suita, Osaka (Japan)
- 4. Osaka University, Graduate School of Science, Department of Chemistry, Toyonaka, Osaka (Japan)
- 5. Fukushima Medical University, Advanced Clinical Research Center, Fukushima (Japan)
- 6. Osaka University, Institute for Radiation Sciences, Division of Science, Toyonaka, Osaka (Japan)
Description
Actinium-225 is one of the most promising nuclides in the field of nuclear medicines for treatments of cancers, whereas the transfer rate of 225Ac during chemical treatments, required for the radiological protection of the radiation workers, has not been determined. In this study, firstly, the chemical operations and the chemical status required for dealing with 225Ac for nuclear medicines were selected, and secondly, the dispersal rate, the surface contamination, and the concentrations of radionuclides in the waste water of 225Ac were determined. The total dispersal rates were determined as low values (2∼4) × 10-6 h-1 and high values (2∼4) × 10-5 h-1, depending on the classes of operations, and that in the exhaust as 1 × 10-7 h-1. These values are about an order of magnitude smaller than that of the "in surface" for normal chemical operations. (author)
Availability note (English)
Available from DOI: https://doi.org/10.12950/rsm.191219Additional details
Identifiers
- DOI
- 10.12950/rsm.191219;
Publishing Information
- Journal Title
- Radiation Safety Management (Online)
- Journal Volume
- 19
- Journal Page Range
- p. 35-48
- ISSN
- 1884-9520
INIS
- Country of Publication
- Japan
- Country of Input or Organization
- Japan
- INIS RN
- 52097559
- Subject category
- S62: RADIOLOGY AND NUCLEAR MEDICINE;
- Descriptors DEI
- ACTINIUM 225; ANTIGEN-ANTIBODY REACTIONS; CLINICAL TRIALS; DRUG DELIVERY; ICRP; RADIATION PROTECTION; RADIOPHARMACEUTICALS; RADIOTHERAPY; SURFACE CONTAMINATION; THERAPEUTIC USES; TUMOR CELLS
- Descriptors DEC
- ACTINIDE NUCLEI; ACTINIUM ISOTOPES; ALPHA DECAY RADIOISOTOPES; ANIMAL CELLS; CONTAMINATION; DAYS LIVING RADIOISOTOPES; DRUGS; HEAVY NUCLEI; INTERNATIONAL ORGANIZATIONS; ISOTOPES; LABELLED COMPOUNDS; MATERIALS; MEDICINE; NUCLEAR MEDICINE; NUCLEI; ODD-EVEN NUCLEI; RADIOACTIVE MATERIALS; RADIOISOTOPES; RADIOLOGY; TESTING; THERAPY; USES
Optional Information
- Notes
- 13 refs., 6 figs., 7 tabs.